Diana Eccles

Active 1992–2024

116
Papers
29,651
Citations
82
h-index
113
i10-index

Citations

Citations per year for Diana Eccles1993: 2 citations1994: 7 citations1995: 10 citations1996: 2 citations1997: 10 citations1998: 19 citations1999: 22 citations2000: 39 citations2001: 24 citations2002: 32 citations2003: 58 citations2004: 100 citations2005: 105 citations2006: 114 citations2007: 183 citations2008: 280 citations2009: 208 citations2010: 306 citations2011: 299 citations2012: 298 citations2013: 358 citations2014: 358 citations2015: 349 citations2016: 395 citations2017: 330 citations2018: 309 citations2019: 863 citations2020: 887 citations2021: 751 citations2022: 518 citations2023: 345 citations2024: 558 citations2025: 222 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,843 citing papers, 21.2% of this breakdownUnited Kingdom: 1,395 citing papers, 10.4% of this breakdownCanada: 670 citing papers, 5% of this breakdownGermany: 664 citing papers, 5% of this breakdownAustralia: 628 citing papers, 4.7% of this breakdownItaly: 576 citing papers, 4.3% of this breakdownChina: 552 citing papers, 4.1% of this breakdownNetherlands: 532 citing papers, 4% of this breakdownFrance: 453 citing papers, 3.4% of this breakdownSpain: 423 citing papers, 3.2% of this breakdownSweden: 338 citing papers, 2.5% of this breakdownDenmark: 275 citing papers, 2% of this breakdown
0%21.2%Other 30.2%

Fields

  • Biochemistry, Genetics and Molecular Biology53.1%
  • Medicine42.1%
  • Computer Science1.1%
  • Immunology and Microbiology1.1%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Neuroscience0.5%
  • Other1.6%

Topics

  • BRCA gene mutations in cancer11.5%
  • Genetic factors in colorectal cancer5.5%
  • DNA Repair Mechanisms4.1%
  • Cancer Genomics and Diagnostics4.1%
  • PARP inhibition in cancer therapy3.4%
  • Genetic Associations and Epidemiology3.1%
  • Other68.3%

Coauthors

All papers

Open in search
  1. Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lucy Side, Jacqueline Eason, Alex Murray, Antonis C. Antoniou, Douglas F. Easton, Zsofia Kote‐Jarai, Rosalind A. Eeles - Journal of Clinical Oncology 2013 cited by 824

  2. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fiona Lalloo, D. Gareth Evans, Douglas F. Easton - The American Journal of Human Genetics 2003 cited by 3,685

  3. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary Porteous, Julian R. Sampson, Rodney J. Scott, Lucy Side - The Lancet 2020 cited by 403

  4. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monica Barile, Sara Volorio, Barbara Pasini, Riccardo Dolcetti, Anna Laura Putignano, Laura Ottini, Paolo Radice, Ute Hamann, Muhammad Usman Rashid, Frans B.L. Hogervorst, Mieke Kriege, Rob B. van der Luijt, Susan Peock, Debra Frost, D. Gareth Evans, Carole Brewer, Lisa Walker, Mark T. Rogers, Lucy Side, Catherine Houghton, JoEllen Weaver, Andrew K. Godwin, Rita K. Schmutzler, Barbara Wappenschmidt, Alfons Meindl, Karin Kast, Norbert Arnold, Dieter Niederacher, Christian Sutter, Helmut Deißler, Doroteha Gadzicki, Sabine Preisler‐Adams, Raymonda Varon-Mateeva, Ines Schönbuchner, Heidrun Gevensleben, Dominique Stoppa‐Lyonnet, Muriel Belotti, Laure Barjhoux, Claudine Isaacs, Beth N. Peshkin, Trinidad Caldés, Miguel de la Hoya, Carmen Cañadas, Tuomas Heikkinen, Päivi Heikkilä, Kristiina Aittomäki, Ignacio Blanco, Conxi Lázaro, Joan Brunet, Bjarni A. Agnarsson, Aðalgeir Arason, Rósa B. Barkardóttir, Martine Dumont, Jacques Simard, Marco Montagna, Simona Agata, Emma D’Andrea, Max Yan, Stephen B. Fox, Timothy R. Rebbeck, Wendy S. Rubinstein, Nadine Tung, Judy E. Garber, Xianshu Wang, Zachary Fredericksen, V. Shane Pankratz, Noralane M. Lindor, Csilla I. Szabo, Kenneth Offit, Rita A. Sakr and 33 more - Cancer Epidemiology Biomarkers & Prevention 2012 cited by 668

  5. Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julian Barwell, Emma McCann, Alex Murray, Antonis C. Antoniou, Douglas F. Easton, on behalf of EMBRACE - JNCI Journal of the National Cancer Institute 2013 cited by 939

  6. Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kunle Odunsi, Simon A. Gayther, Susan M. Domchek, Banu Arun, Karen H. Lu, Gillian Mitchell, Beth Y. Karlan, Christine Walsh, Jenny Lester, Andrew K. Godwin, Harsh B. Pathak, Eric A. Ross, Mary B. Daly, Alice S. Whittemore, Esther M. John, Alexander Miron, Mary Beth Terry, Wendy K. Chung, David E. Goldgar, Saundra S. Buys, Ramūnas Janavičius, Laima Tihomirova, Nadine Tung, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Linda Steele, Susan L. Neuhausen, Yuan Chun Ding, Bent Ejlertsen, Anne‐Marie Gerdes, Thomas van Overeem Hansen, Teresa Ramón y Cajal, Ana Osório, Javier Benı́tez, Javier Godino, María‐Isabel Tejada, M. Durán, Jeffrey N. Weitzel, Kristie Bobolis, Sharon Sand, Annette Campbell Fontaine, Antonella Savarese, Barbara Pasini, Bernard Peissel, Bernardo Bonanni, Daniela Zaffaroni, Francesca Vignolo-Lutati, Giulietta Scuvera, Giuseppe Giannini, Loris Bernard, Maurizio Genuardi, Paolo Radice, Riccardo Dolcetti, Siranoush Manoukian, Valeria Pensotti, Viviana Gismondi, Drakoulis Yannoukakos, Florentia Fostira, Judy E. Garber, Diana Torres, Muhammad Usman Rashid, Ute Hamann, Susan Peock, Debra Frost, Radka Platte, D. Gareth Evans, Rosalind A. Eeles, Rosemarie Davidson, Diana Eccles, Trevor Cole and 158 more - JAMA 2015 cited by 509

  7. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Henry T. Lynch, John C. Mathers, D. Timothy Bishop - The Lancet 2011 cited by 951

  8. Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2014 cited by 370

  9. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

    Authors: , , , , , , , , , , , , , , , - Nature Genetics 2006 cited by 740

  10. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark J. Arends, James M. Bolton, Tjalling Bosse, John Burn, Emma J. Crosbie, Emma J. Crosbie, David N. Church, Joanna M. Cornes, Robin Crawford, K. J. Donnelly, Diana Eccles, Richard J. Edmondson, D. Gareth Evans, Ian M. Frayling, Sadaf Ghaem-Maghami, Paula Gollop, Selina Goodman, Heather Hampel, Shirley Hodgson, Noah D. Kauff, Henry C. Kitchener, Sarah J. Kitson, Fiona Lalloo, Anne Lowry, Ranjit Manchanda, Raymond F.T. McMahon, Rhona J. McVey, Usha Menon, Tracie Miles, Gabriela Möslein, Pål Møller, Kevin Monahan, Adam N. Rosenthal, Neil Ryan, Peter Sasieni, Mourad W. Seif, Pauline Skarrott, Naveena Singh, Tristan Snowsill, R. Steele, Astrid Stormoken, Helen F. Stringfellow, Marc Tischkowitz, Andrew J. Wallace, Luciya Whyte, Nafisa Wilkinson, Godfrey Wilson, Jo Wilson, Nick Wood, D. Gareth Evans - Genetics in Medicine 2019 cited by 235

  11. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria A. Caligo, Mariarosaria Calvello, Gabriele Lorenzo Capone, Sandrine M. Caputo, Ileana Carnevali, Estela Carrasco, Virginie Caux‐Moncoutier, Pietro Cavalli, Giulia Cini, Edward Clarke, Paola Concolino, Elisa J. Cops, Laura Cortesi, Fergus J. Couch, Esther Darder, Miguel de la Hoya, Michael Dean, Irmgard Debatin, Jesús Del Valle, Capucine Delnatte, Nicolas Derive, Orland Dı́ez, Nina Ditsch, Susan M. Domchek, Véronique Dutrannoy, Diana Eccles, Hans Ehrencrona, Ute Enders, D. Gareth Evans, Chantal Farra, Ulrike Faust, Ute Felbor, Irène Feroce, Miriam Fine, William D. Foulkes, Henrique C.R. Galvão, Gaetana Gambino, Andrea Gehrig, Francesca Gensini, Anne‐Marie Gerdes, Aldo Germani, J Giesecke, Viviana Gismondi, Carolina Gómez, E. Gómez, Sara González, Èlia Grau, Sabine Grill, Eva Groß, Aliana Guerrieri‐Gonzaga, Marine Guillaud‐Bataille, Sara Gutiérrez‐Enríquez, Thomas Haaf, Karl Hackmann, Thomas van Overeem Hansen, Marion Harris, Jan Hauke, T. Heinrich, Heide Hellebrand, Karen Herold, Ellen Honisch, Judit Horváth, Claude Houdayer, Verena Hübbel, Sílvia Iglesias, Á. Izquierdo, Paul A. James, Linda A.M. Janssen, Udo Jeschke, Silke Kaulfuß and 121 more - Human Mutation 2019 cited by 152

  12. Therapeutic Targeting of Integrin αvβ6 in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2014 cited by 145

  13. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

    Authors: , , , , , , , , , , , , , , , , - Nature Genetics 2006 cited by 992

  14. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victoria Murday, Catherine Phelan, Steven A. Narod, T. Peretz, Julian Peto, Julian Peto, Barbara L. Weber, Hong Xiang Zhang, Katherine L. Nathanson, David E. Goldgar, Csilla I. Szabo - Nature Genetics 2002 cited by 1,109

  15. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arif B. Ekici, Barbara Burwinkel, Beth Y. Karlan, Børge G. Nordestgaard, Carl Blomqvist, Catherine Phelan, Catriona McLean, Celeste Leigh Pearce, Celine M. Vachon, Cezary Cybulski, Chavdar Slavov, Christa Stegmaier, Christiane Maier, Christine B. Ambrosone, Claus Høgdall, Craig C. Teerlink, Daehee Kang, Daniel C. Tessier, Daniel J. Schaid, Daniel O. Stram, Daniel W. Cramer, David E. Neal, Diana Eccles, Dieter Flesch‐Janys, Digna R. Velez Edwards, Dominika Wokozorczyk, Douglas A. Levine, Drakoulis Yannoukakos, Elinor J. Sawyer, Elisa V. Bandera, Elizabeth M. Poole, Ellen L. Goode, Э. К. Хуснутдинова, Estrid Høgdall, Fengju Song, Fiona Bruinsma, Florian Heitz, Francesmary Modugno, Freddie C. Hamdy, Fredrik Wiklund, Graham G. Giles, Håkan Olsson, Hans Wildiers, Hans-Ulrich Ulmer, Hardev Pandha, Harvey A. Risch, Hatef Darabi, Helga B. Salvesen, Heli Nevanlinna, Henrik Grönberg, Hermann Brenner, Hiltrud Brauch, Hoda Anton‐Culver, Honglin Song, Hui-Yi Lim, Iain A. McNeish, Ian Campbell, Ignace Vergote, Jacek Gronwald, Jan Lubiński, Janet L. Stanford, Javier Benı́tez, Jennifer A. Doherty, Jennifer B. Permuth, Jenny Chang‐Claude, Jenny Donovan, Joe Dennis, Joellen M. Schildkraut, Johanna Schleutker, John L. Hopper and 129 more - Cancer Discovery 2016 cited by 214

  16. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Medical Genetics 2022 cited by 44

  17. Germline mutations in RAD51D confer susceptibility to ovarian cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark T. Rogers, Susan Shanley, Lisa Walker, Diana Eccles, D. Gareth Evans, Anthony Renwick, Sheila Seal, Christopher J. Lord, Alan Ashworth, Jorge S. Reis‐Filho, Antonis C. Antoniou, Nazneen Rahman - Nature Genetics 2011 cited by 537

  18. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Douglas F. Easton - British Journal of Cancer 2008 cited by 535

  19. A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 142

  20. Genome-wide association studies identify four ER negative–specific breast cancer risk loci

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ed Dicks, Will J Howat, Nils Schoof, Stig E. Bojesen, Diether Lambrechts, Annegien Broeks, Irene L. Andrulis, Pascal Guénel, Barbara Burwinkel, Elinor J. Sawyer, Antoinette Hollestelle, Olivia Fletcher, Robert Winqvist, Hermann Brenner, Arto Mannermaa, Ute Hamann, Alfons Meindl, Annika Lindblom, Wei Zheng, Peter Devillee, Mark S. Goldberg, Jan Lubiński, Vessela N. Kristensen, Anthony J. Swerdlow, Hoda Anton‐Culver, Thilo Dörk, Kenneth Muir, Keitaro Matsuo, Anna H. Wu, Paolo Radice, Soo‐Hwang Teo, Xiao‐Ou Shu, William J. Blot, Daehee Kang, Mikael Hartman, Suleeporn Sangrajrang, Chen‐Yang Shen, Melissa C. Southey, Daniel J. Park, Fleur Hammet, Jennifer Stone, Laura J. van’t Veer, Emiel J. Rutgers, Artitaya Lophatananon, Sarah Stewart‐Brown, Pornthep Siriwanarangsan, Julian Peto, Michael Schrauder, Arif B. Ekici, Matthias W. Beckmann, Isabel dos‐Santos‐Silva, Nichola Johnson, Helen R. Warren, Ian Tomlinson, Michael J. Kerin, Nicola Miller, F Marmé, Andreas Schneeweiß, Christof Sohn, Thérèse Truong, Pierre Laurent‐Puig, Pierre Kerbrat, Børge G. Nordestgaard, Sune F. Nielsen, Henrik Flyger, Roger L. Milne, José Ignacio Arias Pérez, Primitiva Menéndez, Heiko Müller, Volker Arndt and 174 more - Nature Genetics 2013 cited by 421

  21. Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study

    Authors: , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2013 cited by 214

  22. Genome-wide association study identifies novel breast cancer susceptibility loci

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suleeporn Sangrajrang, Valérie Gaborieau, Fabrice Odefrey, Chen‐Yang Shen, Pei‐Ei Wu, Hui‐Chun Wang, Diana Eccles, D. Gareth Evans, Julian Peto, Olivia Fletcher, Nichola Johnson, Sheila Seal, Michael R. Stratton, Nazneen Rahman, Georgia Chenevix-Trench, Stig E. Bojesen, Børge G. Nordestgaard, C. K. Axelsson, Montserrat García‐Closas, Louise A. Brinton, Stephen J. Chanock, Jolanta Lissowska, Beata Pepłońska, Heli Nevanlinna, Rainer Fagerholm, Hannaleena Eerola, Daehee Kang, Keun-Young Yoo, Dong‐Young Noh, Sei Hyun Ahn, David J. Hunter, Susan E. Hankinson, David G. Cox, Per Hall, Sara Wedrén, Jianjun Liu, Yen-Ling Low, Natalia Bogdanova, Peter Schürmann, Thilo Dörk, Rob A.�E.�M. Tollenaar, Catharina E. Jacobi, Peter Devilee, Jan G.M. Klijn, Alice J. Sigurdson, Michele M. Doody, Bruce H. Alexander, Jinghui Zhang, Angela Cox, Ian W. Brock, Gordon R. Macpherson, Malcolm Reed, Fergus J. Couch, Ellen L. Goode, Janet E. Olson, Hanne Meijers‐Heijboer, Ans van den Ouweland, André G. Uitterlinden, Fernando Rivadeneira, Roger L. Milne, Gloría Ribas, Anna González‐Neira, Javier Benı́tez, John L. Hopper, Margaret McCredie, Melissa Southey, Graham G. Giles, Chris Schroen, Christina Justenhoven, Hiltrud Brauch and 139 more - Nature 2007 cited by 2,342

  23. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

    Authors: , , , , , , , , , , , , , , , , - Nature Genetics 2006 cited by 755

  24. Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - The Pharmacogenomics Journal 2014 cited by 198